Ahmed Hamdy MD - 09 Aug 2023 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
President and Chief Operations Officer, Director
Signature
By: /s/ Ahmed M. Hamdy
Issuer symbol
VINC
Transactions as of
09 Aug 2023
Net transactions value
+$21,161
Form type
4
Filing time
10 Aug 2023, 18:28:32 UTC
Previous filing
16 Feb 2023
Next filing
08 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VINC Common Stock Purchase $15,994 +16,900 +23% $0.9464 90,660 09 Aug 2023 I The Hamdy Family Trust dated 10/17/2015 F1
transaction VINC Common Stock Purchase $5,167 +5,400 +6% $0.9569 96,060 10 Aug 2023 The Hamdy Family Trust dated 10/17/2015 F2
holding VINC Common Stock 1,618,199 09 Aug 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a weighted average purchase price. Actual purchase prices ranged from $0.88 to $0.95 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.
F2 Represents actual price.

Remarks:

President and Chief Operations Officer